azacitidine and Digestive System Neoplasms

azacitidine has been researched along with Digestive System Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, AT; Cheng, YY; Cheung, KF; Ebert, MP; Jin, H; Li, H; Poon, FF; Röcken, C; Sung, JJ; Tao, Q; Wang, X; Yu, J	1

Other Studies

1 other study(ies) available for azacitidine and Digestive System Neoplasms

Article	Year
Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:2 Topics: Azacitidine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Caspases; Cell Division; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; Digestive System Neoplasms; DNA Methylation; Epigenesis, Genetic; G2 Phase; Gene Silencing; Humans; Hydroxamic Acids; Liver Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin Thiolesterase	2008

Article

Year

Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.

Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:2

Topics: Azacitidine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Caspases; Cell Division; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; Digestive System Neoplasms; DNA Methylation; Epigenesis, Genetic; G2 Phase; Gene Silencing; Humans; Hydroxamic Acids; Liver Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin Thiolesterase

2008